Prevention of gynaecological cancers: in memory of Mario Sideri
Prevention of gynaecological cancers: in memory of Mario Sideri
Inside cancer - public lecture
New approaches in computational pathology for risk assessment in benign breast diseases
Latest trials and outcomes with new CLL treatments
Developing treatments for indolent non hodgkin lymphoma
The evolution of CLL treatment
US breast cancer cases expected to increase by as much as 50 percent by 2030
How to decide the treatment of CLL in 2015
ecancermedicalscience editor's choice for March 2015
Taxane response in prostate cancer may not be influenced by androgen receptor variations
Combination of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma
Genomic profiling may reveal new drug targets in urothelial carcinoma